Cargando…
Clinical Outcomes and Their Prognostic Factors among Cervical Cancer Patients with Bone Recurrence
BACKGROUND: Bone recurrence occurs in 0.75%-8% of cervical cancer patients after primary treatment. Only a few previous studies have reported on survival times associated with prognostic factors for bone recurrent cervical cancer. This study aimed to evaluate the oncological outcomes and their predi...
Autores principales: | Atjimakul, Thiti, Hanprasertpong, Jitti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482514/ https://www.ncbi.nlm.nih.gov/pubmed/36124140 http://dx.doi.org/10.1155/2022/3446293 |
Ejemplares similares
-
Fear of cancer recurrence and its predictors among cervical cancer survivors
por: Hanprasertpong, Jitti, et al.
Publicado: (2017) -
Predictive Value of the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Index on the Oncological Outcomes of Locally Advanced Cervical Cancer Patients
por: Leetanaporn, Kittinun, et al.
Publicado: (2022) -
Impact of diabetes mellitus on oncological outcomes after radical hysterectomy for early stage cervical cancer
por: Jiamset, Ingporn, et al.
Publicado: (2016) -
Safety and Prognostic Impacts of Ovarian Preservation during Radical Hysterectomy for Early-Stage Adenocarcinoma and Adenosquamous Cervical Cancer
por: Theplib, Arisa, et al.
Publicado: (2020) -
Preoperative Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Not Clinically Useful in Predicting Prognosis in Early Stage Cervical Cancer
por: Nuchpramool, Prachratana, et al.
Publicado: (2018)